Delivery Order SPE2DB20D3505-SPE2DB23FT7Q6

Award Date 2/24/23
Potential Completion Date 2/27/23
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,769.18 firm fixed-price contract is for the delivery of AVAPRO 300 MG TABLET 30S, a cardiovascular medication, with a period of performance through November 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,812.53, is for the delivery of AVAPRO 300 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,341.58 firm fixed-price delivery order is for the supply of AVAPRO 150 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2023 and was awarded on October 16, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,637.97 Firm Fixed Price Delivery Order is for the supply of 90-count bottles of 300 mg Irbesartan tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract has a ceiling value of $1,811.45 and a period of performance through March 4, 2025. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency awarded a delivery order valued at fourteen thousand, six hundred thirty-eight dollars and eighty-four cents ($14,638.84) to Amerisourcebergen Drug Corporation for the provision of four hundred fifty-six thousand, one hundred seventy-eight (456,178) Avapro 75 mg tablets. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing from August 11, 2023 through August 14, 2023. As a major component of the Department of Defense supply chain, the...
This federal contract award, valued at $2,202.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg Tablets in 90-count packages, with a completion date of April 28, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Irbesartan 150 mg tablets. The fixed-price delivery order, valued at $3,303.32, has a period of performance through February 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,223.37 firm fixed price delivery order is for the supply of 4,564,960,650 Irbesartan 150 mg tablets in quantities of 90. The award has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award is for the delivery of Irbesartan 150 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,623.10 and is a Firm Fixed Price Delivery Order contract valid through December 16, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FT7Q6
    Delivery Order

This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $3,143.04 and covers the delivery of AVAPRO 150 MG TABLET 30S, a cardiovascular medication, with a performance period ending on February 27, 2023. The contract is not designated as a set-aside. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 10:27 AM